{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:00:38Z","timestamp":1784383238488,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Background: Multiple studies have assessed the appropriateness of the use of medicines for nursing home residents; however, few have included duration of use in their assessment. The aim of this study was to assess the level and duration of use of medications recommended for short-term use in residents of aged care facilities in Australia. Methods: Australian Government Department of Veterans\u2019 Affairs (DVA) administrative claims data were used for this study. Veterans eligible for all health services subsidised by DVA were followed for one year from 1 July 2015 to 30 June 2016. The number of days covered for each medicine was calculated by multiplying the number of prescriptions dispensed during the year by the pack duration for the medicine. The pack duration was calculated by dividing the quantity supplied at each dispensing by the usual number of doses per day in older people according to Australian prescribing guidelines. The proportion of patients using each medicine and the number of days covered during the study period were determined. Results: 14, 237 residents met the inclusion criteria. One in five participants were dispensed antipsychotics, and the median duration of use was 180 days in the one-year period. More than one-third were dispensed a benzodiazepine, and the median duration of use was 240 days in the year. Half were dispensed an opioid analgesic with a median duration of use of 225 days in the year. Fifty-two percent were dispensed proton pump inhibitors with a median duration of use of 360 days in the year. A quarter received an antibiotic recommended for the management of urinary tract infection, with a median duration of use of 14 days in the year. Conclusion: Long-term use of antipsychotics, benzodiazepines, opioid analgesics and proton pump inhibitors is common in aged care residents. Ensuring appropriate duration of use for these medicines is necessary to reduce risk of harm.<\/jats:p>","DOI":"10.3390\/pharmacy7020055","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T03:56:31Z","timestamp":1559879791000},"page":"55","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents"],"prefix":"10.3390","volume":"7","author":[{"given":"Lisa M.","family":"Kalisch Ellett","sequence":"first","affiliation":[{"name":"Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizat M.","family":"Kassie","sequence":"additional","affiliation":[{"name":"Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi","family":"Kerr","sequence":"additional","affiliation":[{"name":"Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Roughead","sequence":"additional","affiliation":[{"name":"Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hup.1160","article-title":"Geriatric drug utilisation of psychotropics in Belgian nursing homes","volume":"26","author":"Azermai","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5694\/mja11.10698","article-title":"A national census of medicines use: A 24-hour snapshot of Australians aged 50 years and older","volume":"196","author":"Morgan","year":"2012","journal-title":"Med. J. Aust."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1532-5415.2006.00889.x","article-title":"Polypharmacy and prescribing quality in older people","volume":"54","author":"Steinman","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Manias, E., Maier, A., and Krishnamurthy, G. (2019). Inappropriate medication use in hospitalised oldest old patients across transitions of care. Aging Clin. Exp. Res., 1\u201313.","DOI":"10.1007\/s40520-018-01114-1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pds.4142","article-title":"Trends in potentially inappropriate medication prescribing to nursing home patients: Comparison of three cross-sectional studies","volume":"26","author":"Halvorsen","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ijpp.12397","article-title":"Polypharmacy and use of potentially inappropriate medications in long-term care facilities: Does coordinated primary care make a difference?","volume":"26","author":"Andrew","year":"2018","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jamda.2015.03.003","article-title":"Prevalence and factors associated with polypharmacy in long-term care facilities: A systematic review","volume":"16","author":"Jokanovic","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel, Fick, D.M., Semla, T.P., Steinman, M., Beizer, J., Brandt, N., Dombrowski, R., DuBeau, C.E., Pezzullo, L., and Epplin, J.J. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc., 67, 674\u2013694.","DOI":"10.1111\/jgs.15767"},{"key":"ref_9","first-page":"213","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"Byrne","year":"2015","journal-title":"Age Ageing"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jamda.2016.06.011","article-title":"Prevalence of potentially inappropriate medication use in older adults living in nursing homes: A systematic review","volume":"17","author":"Morin","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","article-title":"Potentially inappropriate prescribing in community-dwelling older people across Europe: A systematic literature review","volume":"71","author":"Tommelein","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Opondo, D., Eslami, S., Visscher, S., de Rooij, S., Verheij, R., Korevaar, J., and Abu-Hanna, A. (2012). Inappropriateness of medication prescriptions to elderly patients in the primary care setting: A systematic review. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043617"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4140\/TCP.n.2016.385","article-title":"Medication use, falls, and fall-related worry in older adults in the United States","volume":"31","author":"Watanabe","year":"2016","journal-title":"Consult. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.maturitas.2017.01.009","article-title":"Antipsychotic drug use associated with urinary tract infections in older women","volume":"98","author":"Souverein","year":"2017","journal-title":"Maturitas"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10198-015-0676-y","article-title":"Drug overprescription in nursing homes: An empirical evaluation of administrative data","volume":"17","author":"Stroka","year":"2016","journal-title":"Eur. J. Health Econ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2125.2010.03628.x","article-title":"Potentially inappropriate prescribing and cost outcomes for older people: A national population study","volume":"69","author":"Cahir","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_18","unstructured":"Buckley, N. (2019). Australian Medicines Handbook 2019, Australian Medicines Handbook Pty Ltd."},{"key":"ref_19","unstructured":"World Health Organisation Collaborating Centre for Drug Statistics Methodology (2013). Guidelines for ATC Classification and DDD Assignment 2014, WHO. Available online: http:\/\/www.whocc.no\/filearchive\/publications\/2014_guidelines.pdf."},{"key":"ref_20","unstructured":"Australian Government Department of Health and Ageing (2016, September 02). Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Effective 1 March 2014\u201431 March 2014: Commonwealth of Australia, Available online: http:\/\/www.pbs.gov.au\/browse\/publications."},{"key":"ref_21","unstructured":"World Health Organization (2002). International Statistical Classification of Diseases and Related Health Problems 10th Revision, World Health Organization."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hoti, K., Hughes, J., and Sunderland, B. (2012). Medication supply to residential aged care facilities in Western Australia using a centralized medication chart to replace prescriptions. BMC Geriatr., 12.","DOI":"10.1186\/1471-2318-12-25"},{"key":"ref_23","unstructured":"Rossi, S. (2016). Australian Medicines Handbook, Australian Medicines Handbook Pty Ltd."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1753-6405.2009.00357.x","article-title":"Validity of medication-based co-morbidity indices in the Australian elderly population","volume":"33","author":"Vitry","year":"2009","journal-title":"Aust. N. Zeal. J. Public Health"},{"key":"ref_25","unstructured":"Therapeutic Guidelines (2019, April 10). Recurrent Urinary Tract Infections in Adults Melbourne (VIC): Therapeutic Guidelines Ltd.. Available online: https:\/\/tgldcdp.tg.org.au\/viewTopic?topicfile=urinary-tract-infections&guidelineName=Antibiotic#toc_d1e650."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jamda.2016.02.008","article-title":"Central nervous system-acting medicines and risk of hospital admission for confusion, delirium, or dementia","volume":"17","author":"Pratt","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_27","unstructured":"Committee Adaptation Committee (2016). Clinical Practice Guidelines and Principles of Care for People with Dementia, Guideline Adaptation Committee."},{"key":"ref_28","unstructured":"Welfare AIoHa (2019, February 20). Admissions into aged care, People Leaving Aged Care, People\u2019s Care Needs in Aged Care, People Using Aged Care, Services and Places in Aged Care, Available online: https:\/\/www.gen-agedcaredata.gov.au\/Resources\/Access-data\/2013\/December\/Residential-and-community-aged-care-2012%E2%80%9313-suppo."},{"key":"ref_29","first-page":"1","article-title":"Risperidone and risk of cerebrovascular adverse events in dementia patients","volume":"6","author":"Behm","year":"2015","journal-title":"Med. Saf. Update"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1532-5415.2000.tb04729.x","article-title":"Benzodiazepines and the risk of falls in nursing home residents","volume":"48","author":"Ray","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1213\/01.ANE.0000136845.24802.19","article-title":"Postoperative confusion increases in elderly long-term benzodiazepine users","volume":"99","author":"Kudoh","year":"2004","journal-title":"Anesth. Analg."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chao, C.-T., Yang, R.-S., Huang, W.-J., Tsai, K.-S., and Chan, D.-C.D. (2019). Risk Factors for Poor Functional Recovery, Mortality, Recurrent Fractures, and Falls Among Patients Participating in a Fracture Liaison Service Program. J. Am. Med. Dir. Assoc.","DOI":"10.1016\/j.jamda.2018.12.011"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra052321","article-title":"Delirium in older persons","volume":"354","author":"Inouye","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1741-6612.2010.00409.x","article-title":"Review of psychotropic medication in Tasmanian residential aged care facilities","volume":"29","author":"Westbury","year":"2010","journal-title":"Australas. J. Ageing"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.sapharm.2016.02.012","article-title":"Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US","volume":"13","author":"Rane","year":"2017","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jamda.2012.10.018","article-title":"Prevalence and associations of the use of proton-pump inhibitors in nursing homes: A cross-sectional study","volume":"14","author":"Mathieu","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/intqhc\/mzw138","article-title":"Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change","volume":"29","author":"Pratt","year":"2017","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2125.2005.02231.x","article-title":"National Prescribing Service: Creating an implementation arm for national medicines policy","volume":"59","author":"Weekes","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5056\/jnm.2012.18.1.34","article-title":"Prevalence of hidden gastroparesis in the community: The gastroparesis \u201ciceberg\u201d","volume":"18","author":"Rey","year":"2012","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_42","unstructured":"Therapeutic, G.A. (2019, May 01). Domperidone, Australian Product Information 2018, Available online: https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2009-PI-01258-3&d=201903191016933."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","article-title":"Domperidone and risk of ventricular arrhythmia and cardiac death: A systematic review and meta-analysis","volume":"36","author":"Leelakanok","year":"2016","journal-title":"Clin. Drug Investig."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/2\/55\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:56:47Z","timestamp":1760187407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/2\/55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["pharmacy7020055"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy7020055","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}